Pharma Journalist 9038 posts 0 comments

Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics LP, a closely held biotechnology company, announced that the companies have entered into a…
Read More...

Repare Therapeutics Inc. (“Repare”), a precision oncology company pioneering synthetic lethality to develop novel therapeutics that target specific vulnerabilities of tumors in…
Read More...

Regeneron Pharmaceuticals, Inc. and Sanofi announced that the U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) for children aged 6 to 11 years with…
Read More...

Merck, known as MSD outside the United States and Canada, and IAVI, a nonprofit scientific research organization dedicated to addressing urgent, unmet global health challenges,…
Read More...

ArcherDX, Inc. announced a strategic collaboration with AstraZeneca to develop assays to support multiple planned Phase 3 clinical trials for AstraZeneca’s targeted immuno-oncology…
Read More...

ONCODESIGN and HITGEN announced the start of a worldwide strategic alliance in Integrated Drug Discovery Services for the identification and progression of new chemical entities,…
Read More...

Tavotek Biotherapeutics, a biotech company which develops novel biologics for autoimmune diseases and oncology, announced that it has entered into a research agreement with Genmab A/S…
Read More...

Takeda Pharmaceutical Company Limited announced that the U.S. Food and Drug Administration (FDA) approved ALUNBRIG (brigatinib) for adult patients with anaplastic lymphoma…
Read More...

Kleo Pharmaceuticals, Inc. and Celularity, Inc. announced a preclinical research collaboration to rapidly advance synergistic combinations of each company’s technology platform as…
Read More...

Sunovion Pharmaceuticals Inc. (Sunovion) announced that the U.S. Food and Drug Administration (FDA) has approved KYNMOBI (apomorphine HCI) sublingual film (APL-130277) for the acute,…
Read More...